Fenotipos de bronquiolitis y su asociación con desenlaces clínicos en pacientes pediátricos de un hospital de tercer nivel en Barranquilla, 2022–2025

datacite.rightshttp://purl.org/coar/access_right/c_f1cf
dc.contributor.advisorArzuza Ortega, Laura
dc.contributor.advisorStand Niño, Iván
dc.contributor.advisorGarcía Puello, Floralinda
dc.contributor.authorRecalde Palacios, Santiago
dc.contributor.authorFuentes Gómez, Karen Paola
dc.date.accessioned2026-02-10T21:21:15Z
dc.date.available2026-02-10T21:21:15Z
dc.date.issued2025
dc.description.abstractIntroducción: La bronquiolitis es una de las principales causas de morbilidad respiratoria en lactantes, especialmente en países de ingresos medios como Colombia. Su presentación clínica es heterogénea y puede agruparse en fenotipos que reflejan diferentes perfiles de gravedad, pero su utilidad en la predicción de desenlaces clínicos aún requiere mayor evidencia. Objetivo: Determinar la prevalencia de los fenotipos de bronquiolitis y la asociación con desenlaces clínicos: ingreso a UCI, duración de hospitalización y el requerimiento de oxígeno suplementario en pacientes de un hospital pediátrico de tercer nivel en Barranquilla, Atlántico Colombia en el periodo 2022 a 2025-1. Materiales y métodos: Estudio observacional, descriptivo transversal con fase analítica, de carácter retrospectivo, basado en los registros clínicos de pacientes con diagnóstico de bronquiolitis aguda atendidos entre 2022 y 2025. Se seleccionaron 227 casos mediante muestreo aleatorio simple a partir de una población institucional de 2.918 pacientes. Se describieron las características clínicas y se evaluaron asociaciones mediante análisis bivariado y modelos multivariados (regresión binomial negativa y regresiones logísticas ajustadas).spa
dc.description.abstractIntroduction: Bronchiolitis is one of the leading causes of respiratory morbidity in infants, particularly in middle-income countries such as Colombia. Its clinical presentation is heterogeneous and can be grouped into phenotypes that reflect different severity profiles; however, evidence regarding their usefulness in predicting clinical outcomes remains limited. Objective: To determine the prevalence of bronchiolitis phenotypes and their association with clinical outcomes—ICU admission, length of hospital stay, and the need for supplemental oxygen—in patients from a tertiary-level pediatric hospital in Barranquilla, Atlántico, Colombia, during the period 2022 to 2025-1. Materials and methods: This was an observational, descriptive, and analytical retrospective study based on clinical records of patients diagnosed with acute bronchiolitis between 2022 and 2025. A total of 227 cases were selected through simple random sampling from an institutional population of 2,918 patients. Clinical characteristics were described, and associations were evaluated using bivariate analyses and multivariable models (negative binomial regression and adjusted logistic regressions).eng
dc.format.mimetypepdf
dc.identifier.urihttps://hdl.handle.net/20.500.12442/17349
dc.language.isospa
dc.publisherEdiciones Universidad Simón Bolívarspa
dc.publisherFacultaad de Ciencias de la Saludspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationaleng
dc.rights.accessrightsinfo:eu-repo/semantics/embargoedAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectBronquiolitisspa
dc.subjectbronquiolitis viralspa
dc.subjectfenotipos bronquiolitisspa
dc.subjectoxígenospa
dc.subjectconsumo de oxígenospa
dc.subjectobstrucción de las vías aéreasspa
dc.subject.keywordsBronchiolitiseng
dc.subject.keywordsViral bronchiolitiseng
dc.subject.keywordsBronchiolitis phenotypeseng
dc.subject.keywordsOxygeneng
dc.subject.keywordsOxygen consumptioneng
dc.subject.keywordsAirway obstructioneng
dc.titleFenotipos de bronquiolitis y su asociación con desenlaces clínicos en pacientes pediátricos de un hospital de tercer nivel en Barranquilla, 2022–2025spa
dc.type.driverinfo:eu-repo/semantics/other
dc.type.spaOtros
dcterms.referencesBiary N, Desai P. Bronchiolitis. Pediatric Rotations: A Quick Guide for Medical Students 2023;147–153; doi: 10.1007/978-3-031-59873-9_13.eng
dcterms.referencesNair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. The Lancet 2010;375(9725):1545–1555; doi: 10.1016/S0140- 6736(10)60206-1.eng
dcterms.referencesShi T, McAllister DA, O’Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. The Lancet 2017;390(10098):946–958; doi: 10.1016/S0140-6736(17)30938-8.eng
dcterms.referencesJaramillo-Cerezo A, Cardona LV, Arango OI, et al. Bronquiolitis aguda: hospitalización, complicaciones y manejo terapéutico en menores de dos años atendidos en un centro de referencia en 2017 y 2018. Estudio descriptivo. Iatreia 2023;36(3):317–329; doi: 10.17533/UDEA.IATREIA.173.eng
dcterms.referencesAsociación Colombiana de Neumología Pediátrica. Guía de Práctica Clínica Para Bronquiolitis (Diagnóstico Tratamiento y Prevención). 2010.spa
dcterms.referencesManti S, Staiano A, Orfeo L, et al. UPDATE - 2022 Italian guidelines on the management of bronchiolitis in infants. Italian Journal of Pediatrics 2023 49:1 2023;49(1):19-; doi: 10.1186/S13052-022-01392-6.eng
dcterms.referencesDumas O, Mansbach JM, Jartti T, et al. A clustering approach to identify severe bronchiolitis profiles in children. Thorax 2016;71(8):712–718; doi: 10.1136/thoraxjnl2016-208535.eng
dcterms.referencesGadomski AM, Scribani MB. Bronchodilators for bronchiolitis. Cochrane Database of Systematic Reviews 2014;(6); doi: 10.1002/14651858.CD001266.pub4.eng
dcterms.referencesCondella A, Mansbach JM, Hasegawa K, et al. Multicenter study of albuterol use among infants hospitalized with bronchiolitis. Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health 2018;19(3):475; doi: 10.5811/WESTJEM.2018.3.35837.eng
dcterms.referencesSanjuán Marconi MK, Escamilla Arrieta JM, Lequerica Segrera P, et al. Fenotipos clínicos de bronquiolitis aguda y respuesta al salbutamol inhalado en lactantes atendidos en el Hospital Infantil Napoleón Franco Pareja, Cartagena. Revista Ciencias Biomédicas, ISSN-e 2389-7252, ISSN 2215-7840, Vol 9, No 2, 2020, págs 103-118 2020;9(2):103–118.spa
dcterms.referencesAndina Martínez D, Escalada Pellitero S, Viaño Nogueira P, et al. Decrease in the use of bronchodilators in the management of bronchiolitis after applying improvement initiatives. Anales de Pediatría (English Edition) 2022;96(6):476–484; doi: 10.1016/J.ANPEDE.2021.05.014.eng
dcterms.referencesBernet Sánchez A, Bellés Bellés A, García González M, et al. Clinical relevance of viral codetection in infants with respiratory syncytial virus bronchiolitis. Enferm Infecc Microbiol Clin 2024;42(6):308–312; doi: 10.1016/j.eimc.2023.04.009.eng
dcterms.referencesPoço Miranda S, Rodrigues H, Oliveira S. Acute bronchiolitis: The economic impact of non-compliance with national guidelines. J Healthc Qual Res 2024;39(5):299– 305; doi: https://doi.org/10.1016/j.jhqr.2024.06.005.eng
dcterms.referencesLi Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. The Lancet 2022;399(10340):2047–2064; doi: 10.1016/S0140-6736(22)00478-0.eng
dcterms.referencesCiapponi A, Palermo MC, Sandoval MM, et al. Respiratory syncytial virus disease burden in children and adults from Latin America: a systematic review and metaanalysis. Front Public Health 2024;12:1377968; doi: 10.3389/FPUBH.2024.1377968/BIBTEX.eng
dcterms.referencesVillamil JPS, Polack FP, Buendía JA. Disability-adjusted life years for respiratory syncytial virus in children under 2 years. BMC Public Health 2020 20:1 2020;20(1):1679-; doi: 10.1186/S12889-020-09796-X.eng
dcterms.referencesHoefert JA, Molina AL, Gardner HM, et al. De-escalation of High-flow Respiratory Support for Children Admitted with Bronchiolitis: A Quality Improvement Initiative. Pediatr Qual Saf 2022;7(2):E534; doi: 10.1097/PQ9.0000000000000534.eng
dcterms.referencesAl Shibli A, Nouredin MB, Al Amri A, et al. Epidemiology of Bronchiolitis in Hospitalized Infants at Tawam Hospital, Al Ain, United Arab Emirates. Open Respir Med J 2021;15(1):7–13; doi: 10.2174/1874306402115010007.eng
dcterms.referencesBuendia JA, Patino DG, Caballero MT, et al. Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis. F1000Res 2021;10:110–110; doi: 10.12688/F1000RESEARCH.40670.4.eng
dcterms.referencesBottau P, Liotti L, Laderchi E, et al. Something Is Changing in Viral Infant Bronchiolitis Approach. Front Pediatr 2022;10:865977; doi: 10.3389/FPED.2022.865977/BIBTEX.eng
dcterms.referencesWorld Health Organization (WHO). Respiratory Syncytial Virus (RSV). 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/respiratorysyncytial-virus-(rsv) [Last accessed: 12/3/2025].eng
dcterms.referencesInstituto Nacional de Salud. Boletín Epidemiológico Semanal. Semana 47 de 2025. 2025.spa
dcterms.referencesRalston SL, Lieberthal AS, Meissner HC, et al. Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis. Pediatrics 2014;134(5):e1474–e1502; doi: 10.1542/PEDS.2014-2742.eng
dcterms.referencesNational Institute for Health and Care Excellence. Bronchiolitis in children: diagnosis and management (NICE guideline NG9). National Institute for Health and Care Excellence: Guidelines 2021;(August):1–26.eng
dcterms.referencesCanadian Paediatric Society. Bronchiolitis: Recommendations for Diagnosis, Monitoring and Management of Children One to 24 Months | Canadian Paediatric Society. 2021.eng
dcterms.referencesFlorin TA, Plint AC, Zorc JJ. Viral bronchiolitis. The Lancet 2017;389(10065):211– 224; doi: 10.1016/S0140-6736(16)30951-5.eng
dcterms.referencesCastro-Rodriguez JA, Astudillo P, Puranik S, et al. New paradigms in acute viral bronchiolitis: Is it time to change our approach? Paediatr Respir Rev 2025;56:29– 36; doi: 10.1016/J.PRRV.2024.10.004.eng
dcterms.referencesPereira RA, Oliveira de Almeida V, Zambrano M, et al. Effects of nebulized epinephrine in association with hypertonic saline for infants with acute bronchiolitis: A systematic review and meta-analysis. Health Sci Rep 2022;5(3):e598; doi: https://doi.org/10.1002/hsr2.598.eng
dcterms.referencesRodríguez-Martínez CE, Castro-Rodriguez JA, Nino G, et al. The impact of viral bronchiolitis phenotyping: Is it time to consider phenotype-specific responses to individualize pharmacological management? Paediatr Respir Rev 2020;34:53–58; doi: 10.1016/j.prrv.2019.04.003.eng
dcterms.referencesFujiogi M, Dumas O, Hasegawa K, et al. Identifying and predicting severe bronchiolitis profiles at high risk for developing asthma: Analysis of three prospective cohorts. EClinicalMedicine 2022;43:101257; doi: 10.1016/j.eclinm.2021.101257.eng
dcterms.referencesDebnath B, Islam S, Haque N. Prediction of Length of Hospital Stay and Immediate Outcome of Children Suffering From Bronchiolitis on the Bases of Associated Risk Factors. Bangladesh Journal of Infectious Diseases 2020;7(2):67–71; doi: 10.3329/BJID.V7I2.51512.eng
dcterms.referencesFranklin D, Babl FE, Neutze J, et al. Predictors of Intensive Care Admission in Hypoxemic Bronchiolitis Infants, Secondary Analysis of a Randomized Trial. Journal of Pediatrics 2023;256:92-97.e1; doi: 10.1016/j.jpeds.2022.12.006.eng
dcterms.referencesDamore D, Mansbach JM, Clark S, et al. Prospective multicenter bronchiolitis study: Predicting intensive care unit admissions. Academic Emergency Medicine 2008;15(10):887–894; doi: https://doi.org/10.1111/j.1553-2712.2008.00245.x.eng
dcterms.referencesMaglione M, Pierri L, Savoia F, et al. The Path of Bronchiolitis Towards Intensive Care: Risk Factor Analysis in a Large Italian Cohort. Journal of Clinical Medicine 2025, Vol 14, 2025;14(15); doi: 10.3390/JCM14155420.eng
dcterms.referencesGuarnieri V, Palmas G, Trapani S, et al. Exploring Risk Factors Associated With Intensive Care Unit Admission in a Retrospective Cohort of 631 Children With Bronchiolitis. Pediatr Pulmonol 2025;60(1):e27394; doi: https://doi.org/10.1002/ppul.27394.eng
oaire.versioninfo:eu-repo/semantics/acceptedVersion
sb.programaEspecialización en Pediatríaspa
sb.sedeSede Barranquillaspa

Archivos

Bloque original
Mostrando 1 - 2 de 2
No hay miniatura disponible
Nombre:
Resumen.pdf
Tamaño:
192.3 KB
Formato:
Adobe Portable Document Format
No hay miniatura disponible
Nombre:
PDF.pdf
Tamaño:
702.82 KB
Formato:
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
2.93 KB
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones